Clinical Trial Designs in PAH: Shifting From Functional Measurements to Long-term Clinical Outco
Advertisement
Advertisement
Trending on AJMC
1
MASH Fibrosis, Not Resolution, Predicts Mortality: Zobair Younossi, MD
2
FDA Approves Once-Monthly Subcutaneous Olanzapine for Schizophrenia
3
Multi-Hit TP53 Linked to Shorter Survival in Chronic-Phase MPN Cohorts
4
Full POLARGO Data Reveal OS, Safety for Pola-R-GemOx in DLBCL
5